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Patients with type 1 diabetes and those undergoing total pancreatectomy have difficulties achieving normo-
glycemia even with the use of intensive insulin therapy. In these patients, pancreas and pancreatic islet trans-
plantation can be a therapeutic option.
As of July 2017, a total of 302 patients received pancreas transplantation from brain-dead donors in Japan.
The 5-year graft survival in 246 patients by 2015 was 73.9 %. Successful transplantation results in normal daily
blood glucose profiles even after withdrawal of insulin therapy.
A total of 18 cases of islet transplantation were performed in Japan, between 2004 and 2007; 3 of them tempo-
rarily achieved insulin withdrawal. The 5-year islet graft survival was 22.2 %. A nationwide clinical trial examin-
ing the efficacy and safety of islet transplantation is now being conducted.
The currently developed artificial pancreas, to maintain tight blood glucose control automatically, combines
insulin pump and real-time continuous blood glucose monitoring, adjusts insulin doses, and supplies glucose or
glucagon to prevent hypoglycemia. Recent devices have been downsized to almost the same size as smart
phones.
These therapeutic options are undergoing tremendous development; however, there are also advantages
and disadvantages. Physicians and medical staff should support patients and their families in acquiring correct
knowledge about these therapeutic options.
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移植（simultaneous pancreas and kidney transplan-
tation：SPK）を，②腎症のためすでに腎移植を受け
ている患者では膵のみを移植する腎移植後膵移植
（pancreas transplantation after kidney transplanta-
tion：PAK）を，③腎症の合併がない糖尿病患者に対









































































Fig.　2　Atlas of pancreas and kidney transplantation with bladder drainage and enteric drainage3)
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Fig.　4　Changes in HbA1c in 40 patients with type 1 diabetes undergoing successful pan-





































回 8名，2回 4名，3回 6名）行われた．このうち 2













けた 1型糖尿病 48名のうち 42名（88 %）で，移植













Fig.　5　Procedure of pancreatic islet transplantation9)
Table　1　Comparison of pancreas transplantation and pancreas islet transplantation
Pancreas transplantation Pancreas islet transplantation
Classification Organ transplantation Cell transplantation
Method Abdominal operation Portal injection
Anesthesia General anesthesia Topical anesthesia
Graft survival rate at 5 years (%) 73.9 22.2
Major complications Thrombosis, pancreatitis, 
bowel obstruction
Bleeding, portal thrombosis
The number of cases in Japan until July, 2017 302 18
Specification There are many cases and 
the survival rate is high.
The graft survival rate is low, 
but the burden on the patient is small.























用したところ，HbA1cの平均値は 7.4 %から 6.9 %
に低下，目標血糖値を維持できた時間は 66.7 %から
72.2 %に増加し，70 mg/dl以下の低血糖を呈した時
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